Replies to post #29 on Collegium Pharmaceutical Inc (COLL)

[NASDAQ2020]

Sell now and buy back at 15.

Collegium (COLL) has an ER ADF opioid – Xtampza (physical-chemical), an extended-release product for which the company received FDA approval in April 2016 has all three ADF labels. According to the information available, while on the Express Scripts formulary, they are having less than stellar sales and have a small pipeline.